Company Filing History:
1 out of 1 
1 out of 2 Years Active: 2015
Title: The Innovative Contributions of Su Qian
Introduction
Su Qian is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have the potential to combat diabetes. His work is characterized by a focus on aryl glycoside compounds, which have shown promise in inhibiting SGLT activity.
Latest Patents
Su Qian holds 1 patent for an aryl glycoside compound, which includes a preparation method and its uses. The patent discloses an aryl glycoside compound represented by specific formulas, along with its pharmaceutically acceptable salts, optical isomers, and prodrugs. This invention is particularly noteworthy for its ability to inhibit SGLT activity, especially SGLT2, making it a potential diabetes-fighting medicine with great promise.
Career Highlights
Throughout his career, Su Qian has worked with several prominent companies in the science and technology sector. Notably, he has been associated with Shanghai Yingli Science and Technology Co., Ltd and Shanghai Chempartner Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Su Qian has collaborated with various professionals in his field, including his coworker Zusheng Xu, who is a talented woman in the industry. Their joint efforts have likely enhanced the development of innovative solutions in their projects.
Conclusion
In summary, Su Qian is an influential inventor whose work in aryl glycoside compounds holds significant potential for diabetes treatment. His contributions to the pharmaceutical industry are noteworthy and reflect his dedication to innovation.